C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2689158
The present invention provides active metablites of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
L'invention concerne des métabolites actifs de 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile qui modulent l'activité de Janus kinases et sont utiles dans le traitement des maladies relatives à l'activité de Janus kinases comprenant, par exemple, des maladies immunologiques, des affections cutanées, des troubles prolifératifs de myéloïde, des cancers, et d'autres maladies.
Arvanitis Argyrios G.
Rodgers James D.
Shi Jack Guoen
Incyte Corporation
Smart & Biggar
LandOfFree
Metabolites of the janus kinase inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabolites of the janus kinase inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolites of the janus kinase inhibitor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503278